Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-12-02
1996-09-17
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514889, 504127, 504129, 504139, 504153, 504197, 536 252, 536 256, A61K 3170, C07H 2102
Patent
active
055568408
ABSTRACT:
Optically active compounds of the formula ##STR1## wherein n is 1 or 2 and m is 0, 1, 2 or 3 have antiviral activity. Compounds of the formula wherein at least one of the internecleotide phosphorothioate linkages is of the Sp configuration possess increased antiviral activity and/or metabolic stability.
REFERENCES:
patent: 4210746 (1980-07-01), Kerr et al.
patent: 4464359 (1984-08-01), Suhadolnik et al.
patent: 4515781 (1985-05-01), Torrence et al.
patent: 4565696 (1986-01-01), Heath et al.
patent: 4663161 (1987-05-01), Mannino et al.
patent: 4781871 (1988-11-01), West et al.
patent: 4924624 (1990-05-01), Suhadolnik et al.
patent: 5405939 (1995-04-01), Suhadolnik et al.
R. S. Root-Bernstein (I), "Aids Is More Than HIV: Part I," Genetic Engineng News, Sep. 1, 1992, pp. 4-6.
R. S. Root-Bernstein (II), "Aids Is More Than HIV: Part II," Genetic Engineering News, Sep. 15, 1992, pp. 4-5.
Sandstrom, "Antiviral Therapy in Human Immunodeficiency Virus Infection," Drugs, 38(3), 417-450 (1989); see particularly .sctn.4.4.2 (Suramin) at pp. 429-430.
Baum et al., "Aids Research Advances Steadily, But Disease Still Exacting High Toll," Chem. Eng. News, Am. Chem. Soc., Jun. 26, 1989, Washington, D.C., pp. 7-16.
Mitsuya et al, "Rapid In Vitro Systems for Assessing Activity of Agents Against HTLV-III/LAV," Ch. 18 in Aids--Modern Concepts and Therapeutic Challenges, S. Broder ed., Marcel Dekker, Inc., New York, NY, 1987, pp. 303-333.
Sharma et al., "3'-O-Methylated Analogs of 2-5A as Inhibitors of Virus Replication," FEBS Letters, 158(2), 298-300 (1983).
Gaswami et al., "2'-5'-Linked Oligo(adenylic Acid) and Its Analogs," J. Biol. Chem., 257(12), 6867-6870 (1982).
Henderson et al., "Inhibition of Epstein-Barr Virus--Associated Nuclear Antigen (EBNA) Induction by (2'-5')-Oligoadenylate and the Cordycepin Analog: Mechanism of Action for Inhibition of EBV--Induced Transformation," Virology, 122, 198-201 (1982).
Eppstein et al., "Mechanism of Antiviral Activity of (XyloA2'p).sub.2 XyloA," Virology, 131, 341-354 (1983).
"Fourth Drug to Fight HIV Infection Approved by FDA," Chem. Eng. News, Am. Chem. Soc., Washington, DC, 1994, p. 22, col. 1, d4T.
Zon, "Oligonucleotide Analogues as Potential Chemotherapeutic Agents," Pharmaceutical Research, 5(9), 539-549 (1988).
Devash et al., "Multiplication of Tobacco Mosaic Virus in Tobacco Leaf Disks is Inhibited by (2'-5') Oligoadenylate," Science 216, 1415-1416 (1982).
Eppstein et al., "Correlation of Structure of Analogs of ppp(A2'p).sub.2 A and (A2'p).sub.2 A with Stability and Biological Activity", J. Biol. Chem. 257 (22) 13390-13397 (1982).
Jager et al., "Synthesis of Methyl Phosphonate and Methylphosphorotriester Analogues of 2',5'-Adenylate Trimers", Nucleic Acid Res. Symp. Series No. 9, IRL Press Ltd., Longon, GB, pp. 149-152 (1981).
Haugh et al., "Analogues and Analogue Inhibitors of ppp(A2'p).sub.n A Their Stability and Biological Activity" Eur. J. Biochem. 132, 77-84 (1983).
Nelson et al., "Synthesis of P-Thioadenylyl-(2'-5')-adenosine and P-Thioadenylyl-(2'-5')-P-thioadenylyl-(2'-5')-thioadenylyl-(2'-5')-adenosi ne", J. Org. Chem., 49, 2314-2317 (1984).
Eppstein et al., "Stereochemical Configuration Markedly Affects the Biochemical and Biological Properties of Phosphorothioate Analogs of 2-5A Core, (A2'p5').sub.2 A", J. Biol. Chem. 261, 5999-6003 (1986); correction at J. Biol. Chem. 261(29) 13873 (1986).
Lee et al., "2',5'-Oligoadenylates Chiral at Phosphrus: Enzymatic Synthesis, Properties, and Biological Activity or 2',5'-Phosphorothioate Trimer and Tetramer Analogues Synthesized from (S.sub.p)-ATP.alpha.S", Biochemistry 24(3), 551-555 (1985).
Lee et al. (11), "Chiral and Achiral Phosphorothioate Analogs of 2',5'-Oligo(A): Enzymatic Synthesis, Purification and Biological Properties," Fed. Proceedings, 44(5), 1802 (1985) see abstract No. 8126.
Suhadolnik et al., "Chiral and Achiral Phosphorothioate Analogs of 2-5A: Enzymatic Synthesis Characterization and Biological Activities," in The 2-5A System: Molecular and Clinical Aspects of the Interferon--Regulated Pathway, published by Alan R. Liss, Inc., pp. 115-122 (1985).
Pauwels et al., "Biological Activity of New 2-5A Analogs," Chem. Scr. 26(1) 141-145 Chem. Abstr. 105, Abstr. No. 151228t; only Abstr. supplied.
Schryver et al., "2-5A Analogs as Mechanistic Probes of the 2-5A System: Stereoconfiguration of Phosphorothioate Analogs of 2-5A Markedly Influences Metabolic Stability," in The 2-5A System: Molecular and Clinical Aspects of the Interferon--Regulated Pathway, published by Alan R. Liss, Inc., plp. 81-88 (1985).
Bayard et al., "Activation of Ribonuclease L by (2'-5')(A)4-Poly(L-Lysine) Conjugates in Intact Cells", Biochemistry, 26(12), 3730-3736 (1986).
Kariko et al., "Phosphorothioate Analogs of 2-5A. Activation of RNASE L by Trimer Cores and 5'-Monophosphates", Federation Proc. 46(6), Abstr. 922 (1987).
Kariko et al., "Phosphorothioate Analogs of 2-5A: Elucidation of the Stereochemical Course of the Enzymes of the 2-5A Synthetase/RNASE L System", Nucleosides & Nucleotides 6 (1&2), 173-184 (1987).
Lehniger, Biochemistry, Second Edition, Worth Publishers, Inc., New York, NY p. 315 (1978).
Pfleiderer Wolfgang
Suhadolnik Robert J.
Crane L. Eric
Kight John
Temple University - Of The Commonwealth System of Higher Educati
LandOfFree
2',5'-phosphorothioate oligoadenylates as anitiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2',5'-phosphorothioate oligoadenylates as anitiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2',5'-phosphorothioate oligoadenylates as anitiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-413111